Leiomyosarcoma Non Uterine clinical trials

Explore recruiting leiomyosarcoma non uterine clinical trials.

Also recruiting in Europe

Leiomyosarcoma Non Uterine trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Administered INT230-6 (SHAO, VINblastine, CIsplatin) Compared With US Standard of Care in Adult Participants With Locally Recurrent, InoperaBLE, or Metastatic Soft Tissue Sarcomas - (THE INVINCIBLE-3 TRIAL)

Spain, France, Poland, Germany, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Leiomyosarcoma Non Uterine trials by city

Leiomyosarcoma Non Uterine in Toronto Leiomyosarcoma Non Uterine in Vancouver Leiomyosarcoma Non Uterine in Montreal Leiomyosarcoma Non Uterine in Calgary Leiomyosarcoma Non Uterine in Edmonton Leiomyosarcoma Non Uterine in Ottawa Leiomyosarcoma Non Uterine in Winnipeg Leiomyosarcoma Non Uterine in Quebec City Leiomyosarcoma Non Uterine in Hamilton Leiomyosarcoma Non Uterine in Kitchener Leiomyosarcoma Non Uterine in London Leiomyosarcoma Non Uterine in Halifax Leiomyosarcoma Non Uterine in New York Leiomyosarcoma Non Uterine in Los Angeles Leiomyosarcoma Non Uterine in Chicago Leiomyosarcoma Non Uterine in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease